Page last updated: 2024-10-20

uracil and Atrial Remodeling

uracil has been researched along with Atrial Remodeling in 1 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Atrial Remodeling: Long-term changes in the electrophysiological parameters and/or anatomical structures of the HEART ATRIA that result from prolonged changes in atrial rate, often associated with ATRIAL FIBRILLATION or long periods of intense EXERCISE.

Research Excerpts

ExcerptRelevanceReference
" In this study, we explored whether alogliptin, a dipeptidyl peptidase-4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model."7.85Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. ( Jiang, N; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Tse, G; Wang, X; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2017)
" In this study, we explored whether alogliptin, a dipeptidyl peptidase-4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model."3.85Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. ( Jiang, N; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Tse, G; Wang, X; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, X1
Zhang, Z1
Zhao, Y1
Jiang, N1
Qiu, J1
Yang, Y1
Li, J1
Liang, X1
Wang, X1
Tse, G1
Li, G1
Liu, T1

Other Studies

1 other study available for uracil and Atrial Remodeling

ArticleYear
Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.
    Journal of the American Heart Association, 2017, May-15, Volume: 6, Issue:5

    Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Experimental; Dipeptidyl-Peptida

2017